Vertebral Osteomyelitis as a Complication Following Transrectal Biopsy: Case Report and Literature Review
- Authors
-
-
J.J. Tafalla-García
Medical oncology, La Zarzuela Sanitas Hospital, 25 Pléyades st 28023 Madrid Spain -
P. Salinas-Hernández
Medical oncology, La Zarzuela Sanitas Hospital, 25 Pléyades st 28023 Madrid Spain -
M.C. Fernández-Chacón
Medical oncology, La Zarzuela Sanitas Hospital, 25 Pléyades st 28023 Madrid Spain -
J.M. Cuervo- Rodríguez
Medical oncology, La Zarzuela Sanitas Hospital, 25 Pléyades st 28023 Madrid Spain
-
- Keywords:
- Â Prostate, transrectal, biopsy, spondylitis, bacteremia.
- Abstract
-
We present a documented case report of lumbar vertebral osteomyelitis after transrectal biopsy (TRUSB) complicated by sepsis due to Escherichia coli. The Images and histological examination showed an every day more frequent complication. We review the methods of diagnosis and treatment and compare with the scarce literature.
- References
-
Moul JW, Bauer JJ, Srivastava S, et al. Perineal seeding of prostate cancer as the only evidence of clinical recurrence 14 years after needle biopsy and radical prostatectomy: molecular correlation. Urology 1998; 51: 158.
http://dx.doi.org/10.1016/S0090-4295(97)00487-1
Vaghefi H, Magi-Galluzzi C, Klein EA. Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy. Urology 2005; 66: 881.
http://dx.doi.org/10.1016/j.urology.2005.04.005
Eliason O, Dunlap D. Osteomyelitis of the spine following needle biopsy of the prostate. J Urol 1965; 94: 271-5.
De Feo E. Osteomyelitis of the spine following prostatic surgery. Radiology 1954; 62: 396-401.
http://dx.doi.org/10.1148/62.3.396
Zimmerli W. Vertebral osteomyelitis. N Engl J Med 2010; 362: 1022-9.
Rajgopal R, Wang Y. Faber KJ, Izawa JI. Vertebral osteomyelitis following transrectal ultrasound-guided biopsy of the prostate. Can Urol Assoc J 2012; 6(1): e20-22.
Gallina A, Suardi N, Montorsi F, et al. Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men. Int J Cancer 2008; 123: 647-52.
http://dx.doi.org/10.1002/ijc.23559
Boniol M, Boyle P, Autier P, Ruffion A, Perrin P. Critical role of prostate biopsy mortality in the number of year of life gained and lost within a prostate cancer screening program. Br J Urol Int 2012; 110: 1648-53.
http://dx.doi.org/10.1111/j.1464-410X.2012.11513.x
Pinsky PF, Parnes HL, Andriole G. Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial. BJU Int 2014; 113: 254-259.
http://dx.doi.org/10.1111/bju.12368
Nam RK, Saskin R, Lee Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 936-69.
http://dx.doi.org/10.1016/j.juro.2009.11.043
Loeb S, van den Heuvel S, Zhi X, et al. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.Eur Urol 2012; 61: 1110-4.
http://dx.doi.org/10.1016/j.eururo.2011.12.058
Lundstrom K-J, Drevin L, Carlsson S, Garmo H, Loeb S, Stattin P, Bill-Axelson A. Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy. The Journal of Urology 2014; 192(4): 1116-22.
http://dx.doi.org/10.1016/j.juro.2014.04.098
Challacombe B, Dasgupta P, Patel U, Amoroso P, Kirby R. Recognizing and managing the complications of prostate biopsy. The Prostate Centre, Guy’ sand St Thomas’ Hos-pitals NHS Foundation Trust, and Medical Research Council (MRC). Centre for Transplantation, King’ s College London, King’ s Health Partners, Guy’ s Hospital, London, UK.
Simsir A, Kismali E, Mammadov R, Gunaydin G, Cal C. Is It Possible to Predict Sepsis, the Most Serious Complication in Prostate Biopsy? Urol Int 2010; 84: 395-399.
http://dx.doi.org/10.1159/000296290
Digby JM, Kersley JB. Pyogenic non-tuberculous spinal infection: an analysis of thirty cases. J Bone Joint Surg Br 1979; 61: 47.
Beronius M, Bergman B, Andersson R. Vertebral osteomyelitis in Göteborg, Sweden: a retrospective study of patients during 1990-95. Scand J Infect Dis 2001; 33: 527.
Sapico FL, Montgomerie JZ. Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature. Rev Infect Dis 1979; 1: 754.
http://dx.doi.org/10.1093/clinids/1.5.754
Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg 1940; 112: 138.
http://dx.doi.org/10.1097/00000658-194007000-00016
McHenry MC, Rehm SJ, Krajewski LP, et al. Vertebral osteomyelitis and aortic lesions: case report and review. Rev Infect Dis 1991; 13: 1184.
http://dx.doi.org/10.1093/clinids/13.6.1184
Pintado-García V. Espondilitis infecciosa. Servicio de Enfermedades Infecciosas. Hospital Ramón y Cajal. Madrid. España. Enferm Infecc Microbiol Clin 2008; 26(8): 510.
Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004; 364: 369-7.
Nolla JM, Ariza J, Gómez-Vaquero C, et al. Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum 2002; 31: 271.
http://dx.doi.org/10.1053/sarh.2002.29492
Patzakis MJ, Rao S, Wilkins J, et al. Analysis of 61 cases of vertebral osteomyelitis. Clin Orthop Relat Res 1991; 178.
http://dx.doi.org/10.1097/00003086-199103000-00019
Colmenero JD, Jiménez-Mejías ME, Sánchez-Lora FJ, et al. Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis 1997; 56: 709-15.
http://dx.doi.org/10.1136/ard.56.12.709
Loeb S, Carter HB, Berndt S, Ricker W, Schaeffer E. Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011; 186: 1830-4.
- Downloads
- Published
- 2016-04-15
- Issue
- Vol. 5 No. 2 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Vincent Éthier, Marie-Claude Foley, Sarah Higgins, Régen Drouin, Julie Abel, Rabia Temmar, Rami Kotb, Hans Knecht, Overwhelming Paroxysmal Nocturnal Haemoglobinuria in a Patient with Low-Risk Myelodysplastic Syndrome and Long-Term Anticoagulation for Sick Sinus Syndrome , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Hasibe Cingilli Vural, Sadettin Ünsal, Gizem Tosunal, A Real-Time Quantitative PCR Assay for Quantification of c-Myc DNA in Patients who Suffers from Leukemia , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Augusto Bordim, Beatriz Ferreira de Carvalho Patricio, Michelle Álvares Sarcinelli, Marta de Souza Albernaz, Ralph Santos-Oliveira, Nanoradiopharmaceuticals: Development oF Labeling Process for Polymeric Nanoparticles , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Cui Chunxiao, Lin Qing, Liu Xiaoqing, Zhao Jiping, Correlations between the Mammographic Features of Triple-Negative and Triple-Positive Breast Cancer , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- A. Ieni, V. Barresi, G. Giuffrè, G. Tuccari, Lactoferrin in Malignant Human Tumours: New Insights from an Immunohistochemical Meta-Analysis , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Ahmed Abdullah Alhumaidi, Elastic Tissue in Nevus Lipomatosus Cutaneous Superficialis , Journal of Analytical Oncology: Vol. 2 No. 2 (2013)
- Zahra Pezeshki, Mehdi Nematbakhsh, Nitric Oxide Metabolites Change in Cisplatin-Induced Nephrotoxicity: The Effect of L-Arginine and Losartan , Journal of Analytical Oncology: Vol. 2 No. 2 (2013)
- Xin Liu, Yan Chen, Zhi Ping Wu, Cong Guo Jin, Xiao Qun Chen, Jia Li, Yong Chun Zhou, Xi Cai Wang, A DNA Vaccine Targeting the Fetal Liver Kinase-1 (Flk-1) can Activate the Special CD8+ T Cell and Inhibit the Metastasis of Orthotopic Lewis Lung Cancer Model , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Bülent Özgönenel, Öner Özdemir, Melike Özgönenel,, Ronald Thomas, Steven Buck , Süreyya Savasan , The Effect of Pretreatment with Chemotherapeutic Drugs on the Susceptibility to Lymphokine Activated CD8+ T Lymphocyte-Mediated Cytotoxicity in CMK Leukemia Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Martin Czejka, Andreas Kiss, Eva Ostermann, Johannes Schueller, Mansoor Ahmed, Najia Mansoor, Tasneem Ahmad, Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
You may also start an advanced similarity search for this article.